Cartesian Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Cartesian Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cartesian Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cartesian Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $3.0k | 495 | 6.13 |
| 2025-03-31 | $102k | 7.7k | 13.20 |
| 2024-12-31 | $149k | 8.3k | 18.00 |
| 2024-09-30 | $84k | 5.2k | 16.00 |
| 2024-06-30 | $43k | 1.6k | 27.01 |